Your browser doesn't support javascript.
loading
A double-blind, placebo-controlled, phase II, randomized study of lovastatin therapy in the treatment of mildly active rheumatoid arthritis.
Aranow, Cynthia; Cush, John; Bolster, Marcy B; Striebich, Christopher C; Dall'era, Maria; Mackay, Meggan; Olech, Ewa; Frech, Tracy; Box, Jane; Keating, Richard; Wasko, Mary Chester; St Clair, William; Kivitz, Alan; Huang, Weiquang; Ricketts, PetaGay; Welch, Beverly; Callahan, Sherrie; Spychala, Meagan; Boyle, Karen; York, Kate; Keyes-Elstein, Lynette; Goldmuntz, Ellen; Diamond, Betty; Davidson, Anne.
Afiliação
  • Aranow C; The Feinstein Institute for Medical Research, Manhasset, USA.
  • Cush J; Division of Rheumatology, Baylor University Medical Center, Dallas, USA.
  • Bolster MB; Division of Rheumatology, Massachusetts General Hospital, Boston, USA.
  • Striebich CC; Division of Rheumatology, University of Colorado, Denver, USA.
  • Dall'era M; Division of Rheumatology, University of California, San Francisco, USA.
  • Mackay M; The Feinstein Institute for Medical Research, Manhasset, USA.
  • Olech E; Department of Internal Medicine, University of Nevada School of Medicine, Las Vegas, USA.
  • Frech T; Department of Internal Medicine, University of Utah, Internal Medicine, Salt Lake City, USA.
  • Box J; Box Arthritis & Rheumatology of the Carolinas, Charlotte, USA.
  • Keating R; Division of Rheumatology, Scripps Green Hospital, La Jolla, USA.
  • Wasko MC; Division of Rheumatology, Western Pennsylvania Hospital, Pittsburgh, USA.
  • St Clair W; Division of Rheumatology and Immunology, Duke University School of Medicine, Durham, USA.
  • Kivitz A; Altoona Center for Clinical Research, Duncansville, USA.
  • Huang W; The Feinstein Institute for Medical Research, Manhasset, USA.
  • Ricketts P; The Feinstein Institute for Medical Research, Manhasset, USA.
  • Welch B; National Institute of Allergy and Infectious Diseases, NIH, Bethesda, USA.
  • Callahan S; National Institute of Allergy and Infectious Diseases, NIH, Bethesda, USA.
  • Spychala M; Rho Federal Systems Division, Chapel Hill, USA.
  • Boyle K; Rho Federal Systems Division, Chapel Hill, USA.
  • York K; Rho Federal Systems Division, Chapel Hill, USA.
  • Keyes-Elstein L; Rho Federal Systems Division, Chapel Hill, USA.
  • Goldmuntz E; National Institute of Allergy and Infectious Diseases, NIH, Bethesda, USA.
  • Diamond B; The Feinstein Institute for Medical Research, Manhasset, USA.
  • Davidson A; The Feinstein Institute for Medical Research, Manhasset, USA.
Rheumatology (Oxford) ; 59(7): 1505-1513, 2020 07 01.
Article em En | MEDLINE | ID: mdl-31628482
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Proteína C-Reativa / Lovastatina / Inibidores de Hidroximetilglutaril-CoA Redutases Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Rheumatology (Oxford) Assunto da revista: REUMATOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Proteína C-Reativa / Lovastatina / Inibidores de Hidroximetilglutaril-CoA Redutases Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Rheumatology (Oxford) Assunto da revista: REUMATOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos